<DOC>
	<DOCNO>NCT00925392</DOCNO>
	<brief_summary>This study perform measure amount antibiotic doripenem ( study drug ) find fluid cell lung blood receiving three dos doripenem . The major objective research see much long doripenem get fluids cell lungs healthy adult subject .</brief_summary>
	<brief_title>Doripenem Intrapulmonary Pharmacokinetics Healthy Adult Subjects</brief_title>
	<detailed_description>The primary objective descriptive study determine compare plasma , epithelial lining fluid ( ELF ) , alveolar macrophage ( AM ) concentration follow multiple intravenous dos doripenem healthy , non-smoking adult subject . In brief , subject qualifies study randomize one two dose regimen : doripenem 500 mg doripenem 1000 mg every 8 hour total three intravenous dos . Each dose doripenem administer intravenous infusion 4 hour . Serial blood sample determine plasma doripenem concentration collect prior start intravenous infusion third doripenem dose . Each subject undergo one standardized bronchoscopy BAL outpatient bronchoscopy suite one four sample time start intravenous infusion third doripenem dose . BAL collection provide sample determine drug concentration ELF AM . Safety assess throughout study adverse event monitoring , clinical laboratory test , vital sign monitoring .</detailed_description>
	<criteria>Healthy men woman least 18 year age history smoking within last 1 year . Subjects must healthy clinically important abnormality medical history , physical examination , laboratory value . Subjects must history allergic serious reaction doripenem betalactam antibiotic , benzodiazepine lidocaine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>doripenem</keyword>
	<keyword>epithelial lining fluid</keyword>
	<keyword>alveolar macrophage</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>Healthy adult subject</keyword>
</DOC>